J&J buys wellness firm HealthMedia

Share this article:
J&J buys wellness firm HealthMedia
J&J buys wellness firm HealthMedia

Johnson & Johnson (J&J) is getting into the wellness and prevention business with the acquisition of HealthMedia, Inc., an online “health coach” for consumers.

Described as a “web-based behavior change interventions” company, HealthMedia represents the beginning of a new business platform for J&J, the company said in a statement.

“It is exciting for Johnson & Johnson to establish a new business platform to offer customers meaningful products and services…that reduce healthcare costs, and at the same time, deliver new growth for our company,” said William Weldon, J&J's chairman and CEO. “Our establishment of a wellness and prevention platform recognizes our conviction that a comprehensive solution must begin long before the onset of illness.”

HealthMedia, of Ann Arbor, MI, was founded in 1998 by Victor Strecher. According to the company's website, HealthMedia's products are “backed by 30-plus years of behavior science research born out at the Health Media Research Laboratory at the University of Michigan."

J&J was not immediately available for comment.

 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...